drugset / Trial / NCT01142622

Intraperitoneal Ropivacaine Nebulization for Pain Control After Gynecologic Laparoscopic Surgery

NCT01142622

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess if intraperitoneal nebulization of Ropivacaine 150 mg may prevent the use of morphine during the first day after laparoscopic ovarian cyst surgery.

Timeline

Start
2010-04
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 150 mg Other

Indications